AI assistant
Sending…
STEPAN CO — Director's Dealing 2017
Mar 2, 2017
32175_dirs_2017-03-02_460070ac-770a-40fd-a6b1-77c0d9aca3ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEPAN CO (SCL)
CIK: 0000094049
Period of Report: 2017-02-28
Reporting Person: Behrens Scott R. (VP/GM Surfactants)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-28 | Common Stock | M | 3553 | $41.16 | Acquired | 8045.071 | Direct |
| 2017-02-28 | Common Stock | D | 1922 | $76.10 | Disposed | 6123.071 | Direct |
| 2017-02-28 | Common Stock | F | 508 | $76.10 | Disposed | 5615.071 | Direct |
| 2017-03-01 | Common Stock | S | 400 | $79.3775 | Disposed | 5215.071 | Direct |
| 2017-03-01 | Common Stock | S | 100 | $79.465 | Disposed | 5115.071 | Direct |
| 2017-03-01 | Common Stock | S | 417 | $79.49 | Disposed | 4698.071 | Direct |
| 2017-03-01 | Common Stock | S | 100 | $79.50 | Disposed | 4598.071 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-28 | Stock Appreciation Right | $41.16 | M | 3553 | Disposed | 2025-02-16 | Common Stock (3553) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3326.516 | Indirect |
Footnotes
F1: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award.
F2: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs.
F3: Withholding of shares to satisfy tax liability on exercise of SARs.
More from STEPAN CO
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19